Mild-to-moderate chronic cholestatic liver disease increases leucine oxidation in children

Area of Science:

• Pediatric Gastroenterology
• Nutritional Science
• Hepatology

Background:

• Malnutrition is common in children with chronic cholestatic liver disease.
• Previous studies indicated an increased need for branched-chain amino acids (BCAA) in these children.
• The mechanisms behind this elevated BCAA requirement were not fully understood.

Purpose of the Study:

• To investigate the underlying mechanisms of increased BCAA requirements in children with mild-to-moderate chronic cholestatic (MCC) liver disease.
• To measure leucine oxidation rates in children with MCC liver disease and healthy controls.
• To determine if increased leucine oxidation contributes to the elevated BCAA needs.

Main Methods:

• Utilized the noninvasive indicator amino acid oxidation (IAAO) technique.
• Measured L-[1-(13C)]-leucine oxidation to 13CO2 (F13CO2) in postabsorptive and fed states.
• Administered a primed, continuous oral dose of the L-[1-(13C)]-leucine tracer.
• Ensured adequate dietary BCAA intake to exceed requirements.

Main Results:

• Children with MCC liver disease exhibited significantly higher F13CO2 and whole-body leucine oxidation in the postabsorptive state compared to controls (P < 0.05).
• No significant differences in F13CO2 or whole-body leucine oxidation were observed between groups in the fed state.
• These findings suggest a state-dependent alteration in leucine metabolism.

Conclusions:

• The increased dietary BCAA requirement in children with MCC liver disease is partially explained by elevated leucine oxidation during the postabsorptive period.
• This study highlights the importance of considering metabolic alterations in nutritional management of pediatric liver disease.
• The IAAO technique provides a valuable tool for assessing amino acid metabolism in pediatric liver conditions.